These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 9487627)
1. [Clinical picture, diagnosis and therapy of acromegaly patients in Eastern and Western Germany]. Teubner A; Breidert M; Baehring T; Hensen J; Bornstein SR Z Arztl Fortbild Qualitatssich; 1997 Dec; 91(8):739-45. PubMed ID: 9487627 [TBL] [Abstract][Full Text] [Related]
2. [Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey]. Priem S; Munkelt K; Franz JK; Schneider U; Werner T; Burmester GR; Krause A Z Rheumatol; 2003 Oct; 62(5):450-8. PubMed ID: 14579032 [TBL] [Abstract][Full Text] [Related]
3. [What is the value of determining immunoreactive GHRH in acromegaly?]. Müller B; de Marco D; Bürgi U; Mullis PE Schweiz Med Wochenschr; 1999 Aug; 129(33):1152-61. PubMed ID: 10483668 [TBL] [Abstract][Full Text] [Related]
4. The choice of therapy in acromegaly: results of treatment at a tertiary care hospital. Isidro ML; Castro JA; Penín M; Armenta J; Cordido F Neuro Endocrinol Lett; 2008 Dec; 29(6):1038-44. PubMed ID: 19112390 [TBL] [Abstract][Full Text] [Related]
5. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Resmini E; Minuto F; Colao A; Ferone D Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513 [TBL] [Abstract][Full Text] [Related]
6. Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients. Resmini E; Barreca A; Ferone D; Giusti M; Sidoti M; Minuto F Clin Endocrinol (Oxf); 2005 Sep; 63(3):294-7. PubMed ID: 16117816 [TBL] [Abstract][Full Text] [Related]
7. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Minuto F; Resmini E; Boschetti M; Arvigo M; Sormani MP; Giusti M; Ferone D; Barreca A Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656 [TBL] [Abstract][Full Text] [Related]
8. Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective. Patel YC; Ezzat S; Chik CL; Rorstad OP; Serri O; Ur E; Wilkins GE Clin Invest Med; 2000 Jun; 23(3):172-87. PubMed ID: 10911548 [TBL] [Abstract][Full Text] [Related]
9. [The importance of early diagnosis in acromegaly]. Valkusz Z; Tóth M; Boda J; Nagy E; Julesz J Orv Hetil; 2011 May; 152(18):696-702. PubMed ID: 21498157 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of differentiated thyroid carcinoma in acromegaly. Tita P; Ambrosio MR; Scollo C; Carta A; Gangemi P; Bondanelli M; Vigneri R; degli Uberti EC; Pezzino V Clin Endocrinol (Oxf); 2005 Aug; 63(2):161-7. PubMed ID: 16060909 [TBL] [Abstract][Full Text] [Related]
11. [Acromegaly: a disorder with distinguished features yet delayed diagnosis]. Rácz K; Tóth M; Jakab C; Patócs A; Kiss R Orv Hetil; 2002 May; 143(19 Suppl):1052-7. PubMed ID: 12063859 [TBL] [Abstract][Full Text] [Related]
12. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution. Jallad RS; Musolino NR; Salgado LR; Bronstein MD Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910 [TBL] [Abstract][Full Text] [Related]
13. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy. Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Schneider HJ; Sievers C; Saller B; Wittchen HU; Stalla GK Clin Endocrinol (Oxf); 2008 Sep; 69(3):432-5. PubMed ID: 18284644 [TBL] [Abstract][Full Text] [Related]
15. Hormonal diagnosis of GH hypersecretory states. Grottoli S; Gasco V; Ragazzoni F; Ghigo E J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657 [TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes and mortality of 94 patients with acromegaly. Trepp R; Stettler C; Zwahlen M; Seiler R; Diem P; Christ ER Acta Neurochir (Wien); 2005 Mar; 147(3):243-51; discussion 250-1. PubMed ID: 15627919 [TBL] [Abstract][Full Text] [Related]
17. A follow-up of 130 patients with acromegaly in a single centre. Bolanowski M; Zatonska K; Kaluzny M; Zielinski G; Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Daroszewski J; Szymczak J; Podgorski JK Neuro Endocrinol Lett; 2006 Dec; 27(6):828-32. PubMed ID: 17187024 [TBL] [Abstract][Full Text] [Related]
18. The German Acromegaly Registry: description of the database and initial results. Reincke M; Petersenn S; Buchfelder M; Gerbert B; Skrobek-Engel G; Franz H; Lohmann R; Quabbe HJ Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):498-505. PubMed ID: 17115347 [TBL] [Abstract][Full Text] [Related]
19. [What is the interest of Klinefelter's syndrome for (child) psychiatrists?]. Kebers F; Janvier S; Colin A; Legros JJ; Ansseau M Encephale; 2002; 28(3 Pt 1):260-5. PubMed ID: 12091788 [TBL] [Abstract][Full Text] [Related]
20. Changing patterns in diagnosis and therapy of acromegaly over two decades. Nachtigall L; Delgado A; Swearingen B; Lee H; Zerikly R; Klibanski A J Clin Endocrinol Metab; 2008 Jun; 93(6):2035-41. PubMed ID: 18381584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]